Trial Profile
Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms PAFRIOSIES
- 31 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2009 Planned end date changed from 1 Dec 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 22 Jun 2007 New trial record.